Dr. William Keith Engel, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 6060 Clearwater Dr Ste 150, Minnetonka, MN 55343 Phone: 763-416-7600 Fax: 763-416-7634 |
Dr. Eugene O Gullingsrud, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10709 Wayzata Blvd Ste 200, Minnetonka, MN 55305 Phone: 952-888-5800 Fax: 952-567-6156 |
Thomas W Samuelson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10709 Wayzata Blvd Ste 200, Minnetonka, MN 55305 Phone: 952-888-5800 Fax: 952-567-6156 |
Dr. Richard S Freeman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6060 Clearwater Dr Ste 150, Minnetonka, MN 55343 Phone: 763-416-7600 Fax: 763-416-7634 |
Dr. Phillip Michael Armand Radke, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 15111 Twelve Oaks Center Dr, Minnetonka, MN 55305 Phone: 952-993-4500 |
Dr. Michael Lieppman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 15111 Twelve Oaks Center Dr, Minnetonka, MN 55305 Phone: 952-993-4500 |
News Archive
The drug RPL554 apparently has the potential to effectively treat the respiratory diseases but without many of the side-effects most currently available drugs produce.
Using a special type of magnetic resonance imaging, researchers have found that soldiers who suffered mild traumatic brain injury induced by blast exposure exhibit long-term brain differences, according to a study being presented today at the annual meeting of the Radiological Society of North America.
"Unintentional poisoning is now the second leading cause of unintentional death in the US," reports Dr. Jeffrey H. Coben of West Virginia University School of Medicine in Morgantown. Among people 35 to 54 years old, unintentional poisoning surpassed motor vehicle crashes as the leading cause of unintentional death in 2005.
In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells. The study is scheduled for the Sept. 9 issue of ACS' Nano Letters, a monthly journal.
› Verified 7 days ago